2007
DOI: 10.1016/j.biotechadv.2007.01.006
|View full text |Cite
|
Sign up to set email alerts
|

Immunogenicity of therapeutic proteins. Part 2: Impact of container closures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
35
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 93 publications
(35 citation statements)
references
References 24 publications
0
35
0
Order By: Relevance
“…Furthermore, contact materials such as glass, steel, silicone, plastic, rubbers, etc. may influence aggregation 78 where histidine formulated bulk of an IgG1 including sodium chloride resulted in high aggregate levels when stored in a stainless steel tank. 79 …”
Section: Solvent and Surface Effectsmentioning
confidence: 98%
“…Furthermore, contact materials such as glass, steel, silicone, plastic, rubbers, etc. may influence aggregation 78 where histidine formulated bulk of an IgG1 including sodium chloride resulted in high aggregate levels when stored in a stainless steel tank. 79 …”
Section: Solvent and Surface Effectsmentioning
confidence: 98%
“…There may even be losses to container closures (Sharma 2007) and residual metals (e.g. tungsten in syringes; Bee et al 2009c) are known to interact with protein products, causing aggregation.…”
Section: Figure 2 Herementioning
confidence: 99%
“…[5][6][7] Interactions between proteins and foreign materials, such as rubber, metal particles, and administration devices, can also occur. [8][9][10][11][12] For injectable formulations, syringes (glass or polypropylene) and needles are used for reconstitution and administration. In these devices, silicone oil is used as a lubricant for ease of handling.…”
mentioning
confidence: 99%